Integration of bioinformatics and experimental validation highlights VDAC1's clinical significance in lung adenocarcinoma, suggesting its utility as a therapeutic target.
This study integrates bioinformatic insights with experimental validation to clarify the clinical significance and therapeutic potential of VDACs in LUAD, providing a valuable foundation for prognosis assessment and targeted therapy development.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: